Home / Inspections / 1327366

FDA Inspection 1327366 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567044

The FDA completed an inspection of Regenerative Biologics, Inc. on July 14, 2026 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Melbourne, FL (United States)

Facility

Other inspections at this facility

  • 924832 (NAI Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 796524 (NAI Wed Aug 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 671922 (NAI Wed Jul 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources